查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830951

心血管超音波心臟检查市场

Cardiovascular Echocardiography Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

心血管超音波心臟检查市场预计将从 2024 年的 1.5437 亿美元成长到 2031 年的 2.2214 亿美元，预计 2025 年至 2031 年的复合年增长率为 5.5%。

市场洞察与分析师观点：心血管超音波心动图是一种用于评估心臟的医学影像技术。它利用声波产生心臟结构的视觉影像。此检查通常用于疑似或确诊心臟病的患者。除了提供心腔和瓣膜的大小和形状资讯外，它还透过测量心输出量、射血分数和舒张功能来评估心臟功能。超音波心动图可以识别心肌病变，并可视化先前心臟病发作造成的损伤。各种心臟超音波检查，包括经胸超音波心臟检查、经食道心臟超音波和负荷超音波心动图，都可用于诊断。心血管疾病盛行率的不断上升和老龄人口的不断增长预计将为心血管超音波心动图市场创造巨大的成长机会。

成长驱动因素：在评估心臟病发作、胸痛、冠状动脉疾病、血栓和其他心臟问题时，医生通常会建议进行涉及血液检查和心导管插入术的侵入性操作。这种侵入性方法需要延长住院时间，并可能导致出血、血栓和动脉损伤等併发症。因此，医师倾向于限制使用心导管插入术进行心臟诊断，转而选择非侵入性方法，例如核心脏压力测试、磁振造影、心臟超音波和冠状动脉CT血管摄影。

超音波心动图是继心电图和胸部X光之后最常用的心血管诊断方法。它是一种非侵入性检查，能够提供关于心臟功能和血流动力学的宝贵资讯。与其他使用放射线的诊断方法相比，超音波心动图的风险极低，因此已被医院和诊断中心广泛采用。此外，有心臟衰竭病史的患者可以透过这些诊断方法进行定期监测，从而受益，这有助于追踪病情进展和治疗效果。超音波心动图也用于有心臟毒性风险的癌症患者的持续护理。

超音波心动图设备相对于其他心臟诊断方法的优势推动了其被采用，从而推动了心血管超音波心动图市场的成长。

心血管超音波心动图市场的当前趋势包括将人工智慧和其他尖端技术整合到超音波心动图设备中。

战略洞察

报告细分和范围：心血管超音波心动图市场分析涵盖以下几个方面：类型、技术、最终用户和地理。依类型划分，市场分为经胸超音波心臟检查、经食道超音波心动图、负荷超音波心动图和胎儿超音波心臟检查。依技术划分，市场分为二维超音波心动图、三维超音波心动图和多普勒超音波心动图。依最终用户划分，市场分为医院、门诊手术中心和诊断实验室。心血管超音波心动图市场报告的地理范围包括北美（美国、加拿大和墨西哥）、欧洲（法国、德国、英国、西班牙、义大利和欧洲其他地区）、亚太地区（中国、日本、印度、澳洲、韩国和亚太其他地区）、中东和非洲（沙乌地阿拉伯、南非、阿联酋和中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲（巴西、阿根廷和南美洲和中美洲）。

細項分析：心血管超音波心臟检查市场依类型分为经胸超音波心臟检查、负荷超音波心动图、经食道心臟超音波和胎儿超音波心臟检查。经胸超音波心臟检查细分市场在2022年占据了相当大的市场份额，预计在2022年至2030年期间将呈现最高的复合年增长率。

依技术划分，市场分为二维超音波心动图、三维超音波心动图和多普勒超音波心动图。 2022年，三维超音波心动图占据了心血管超音波心动图市场的很大份额，预计在2022年至2030年期间将实现最高的复合年增长率。

依最终用户划分，市场分为医院、门诊手术中心和诊断实验室。 2022年，医院市场在心血管超音波心动图市场中占据了相当大的份额，预计在2022年至2030年期间将实现最高的复合年增长率。

心血管超音波心动图市场报告范围

区域分析：心血管超音波心臟检查市场按区域划分，可分为北美、欧洲、亚太地区、南美和中美以及中东和非洲。 2022年，北美占据了相当大的市场份额，其中美国在该区域处于领先地位。北美市场的成长归因于心臟病发病率的上升、老龄人口的增加以及该地区主要市场参与者的存在。

心臟病是美国的主要死因。根据美国疾病管制与预防中心 (CDC) 的数据，美国每年约有 805,000 人心臟病发作。此外，冠状动脉心臟病是最常见的心臟病形式，2019 年导致 360,900 人死亡。 CDC 估计，到 2030 年，美国将有约 1,210 万人患有心房颤动。同样，加拿大慢性疾病监测系统报告称，大约每 12 个（260 万）20 岁及以上的加拿大成年人中就有 1 个被诊断患有心臟病。加拿大统计局表示，2020 年有 67,399 人死于心臟病或中风。因此，心血管疾病盛行率的上升影响了很大一部分人口，导致对心血管超音波心动图等诊断工具的需求增加，以评估和监测心血管健康，从而推动了该地区的市场发展。

竞争格局与关键参与者：心血管超音波心动图市场的预测可以帮助利害关係人制定成长策略。心血管超音波心臟检查市场报告中介绍的主要参与者包括Apex Heart and Vascular、Ultra-X Imaging、Metropolitan Heart Vascular Institute、Ultromics Limited、Corewell Health、Centinela Hospital Medical Center、Schoolcraft Memorial Hospital、犹他大学健康中心、Goshen Heart & Vascular Center和Harefield Hospitalcular Center和Harefield Hospitalcular Center。这些公司专注于推出新的高科技产品、增强现有产品组合併拓展地理范围，以满足日益增长的全球消费者需求。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：心血管超音波心臟检查市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：心血管超音波心臟检查市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：心血管超音波心臟检查市场-全球市场分析

  • 心血管超音波心臟检查 - 全球市场概览
  • 心血管超音波心臟检查—全球市场及2031年预测

第七章：心血管超音波心臟检查市场-收入分析-依类型，2021-2031

  • 概述
  • 经胸超音波心臟检查
  • 经食道心臟超音波
  • 负荷超音波心臟检查
  • 胎儿超音波心臟检查

第 8 章：心血管超音波心动图市场 - 收入分析 - 按技术，2021-2031 年

  • 概述
  • 二维超音波心动图
  • 3D超音波心臟检查
  • 多普勒

第 9 章：心血管超音波心动图市场 - 收入分析 - 按最终用户，2021-2031 年

  • 概述
  • 医院
  • 门诊手术中心
  • 诊断实验室

第 10 章：心血管超音波心动图市场 - 收入分析，2021-2031 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 12 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 13 章：心血管超音波心动图市场 - 主要公司简介

  • Apex Heart and Vascular
  • Ultra-X Imaging
  • Metropolitan Heart Vascular Institute
  • Ultromics Limited
  • Corewell Health
  • Centinela Hospital Medical Center
  • Schoolcraft Memorial Hospital
  • University of Utah Health
  • Goshen Heart and Vascular Center
  • Harefield Hospital

第 14 章：附录

简介目录
Product Code: TIPHE100000964

The cardiovascular echocardiography market is anticipated to grow to US$ 222.14 million by 2031, up from US$ 154.37 million in 2024, reflecting a projected CAGR of 5.5% from 2025 to 2031.

Market Insights and Analyst Perspective:Cardiovascular echocardiography is a medical imaging technique used to assess the heart. It employs sound waves to generate visual representations of the heart's structure. This procedure is typically conducted on patients with suspected or confirmed heart conditions. In addition to providing information about the size and shape of the heart's chambers and valves, it also evaluates heart function by measuring cardiac output, ejection fraction, and diastolic function. Echocardiograms can identify cardiomyopathies and visualize damage from previous heart attacks. Various cardiac ultrasound tests, including transthoracic, transesophageal, and stress echocardiography, are performed for diagnostic purposes. The increasing prevalence of cardiovascular diseases and the expanding elderly population are expected to create significant growth opportunities for the cardiovascular echocardiography market.

Factors Driving Growth:In the assessment of heart attacks, chest pain, coronary artery disease, blood clots, and other cardiac issues, physicians often recommend invasive procedures that involve blood tests and cardiac catheterization. This invasive approach requires extended hospital stays and can lead to complications such as bleeding, blood clots, and arterial damage. Consequently, doctors tend to limit the use of catheterization for cardiac diagnosis, opting instead for noninvasive alternatives like nuclear cardiac stress tests, magnetic resonance imaging, cardiac ultrasound, and coronary computed tomography angiograms.

Echocardiography ranks as the most frequently utilized cardiovascular diagnostic test following electrocardiography and chest X-rays. It is a noninvasive procedure that provides valuable insights into cardiac function and hemodynamics. Given the minimal risks associated with echocardiograms compared to other diagnostic methods that utilize radiation, there has been widespread adoption of these devices in hospitals and diagnostic centers. Additionally, patients with a history of heart failure benefit from regular monitoring through these diagnostics, which aids in tracking disease progression and treatment efficacy. Echocardiograms are also employed in the ongoing care of cancer patients at risk of cardiotoxicity.

The benefits of echocardiographic devices over other cardiac diagnostic methods drive their adoption, thus propelling the growth of the cardiovascular echocardiography market.

Current trends in the cardiovascular echocardiography market include the integration of AI and other cutting-edge technologies into echocardiography devices.

Strategic Insights

Report Segmentation and Scope:The analysis of the cardiovascular echocardiography market has been conducted by examining the following segments: type, technology, end user, and geography. By type, the market is divided into transthoracic echocardiography, transesophageal echocardiography, stress echocardiography, and fetal echocardiography. In terms of technology, the market is categorized into 2D echocardiograms, 3D echocardiograms, and Doppler echocardiograms. Based on end user, the market is segmented into hospitals, ambulatory surgery centers, and diagnostic laboratories. The geographical scope of the cardiovascular echocardiography market report includes North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Segmental Analysis:The cardiovascular echocardiography market is categorized by type into transthoracic echocardiography, stress echocardiography, transesophageal echocardiography, and fetal echocardiography. The transthoracic echocardiography segment held a substantial market share in 2022 and is expected to exhibit the highest CAGR during the period from 2022 to 2030.

In terms of technology, the market is divided into 2D echocardiograms, 3D echocardiograms, and Doppler echocardiograms. The 3D echocardiogram segment accounted for a significant share of the cardiovascular echocardiography market in 2022 and is projected to achieve the highest CAGR from 2022 to 2030.

By end user, the market is segmented into hospitals, ambulatory surgery centers, and diagnostic laboratories. The hospitals segment represented a significant share of the cardiovascular echocardiography market in 2022 and is anticipated to register the highest CAGR during the period from 2022 to 2030.

Cardiovascular Echocardiography Market Report Scope

Regional Analysis:Regionally, the cardiovascular echocardiography market is divided into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held a considerable share of the market, with the US leading in this region. The growth of the market in North America is attributed to the rising incidence of heart diseases, an increasing elderly population, and the presence of major market players in the area.

Heart disease is a leading cause of mortality in the US. According to the Centers for Disease Control and Prevention (CDC), approximately 805,000 individuals experience a heart attack annually in the US. Furthermore, coronary heart disease is the most prevalent form of heart disease, resulting in 360,900 deaths in 2019. The CDC estimates that by 2030, around 12.1 million people in the US will have atrial fibrillation. Similarly, the Canadian Chronic Disease Surveillance System reports that about 1 in 12 (2.6 million) Canadian adults aged 20 and older are diagnosed with heart disease. Statistics Canada indicates that 67,399 individuals died from heart disease or stroke in 2020. Thus, the increasing prevalence of cardiovascular diseases impacts a large segment of the population, leading to heightened demand for diagnostic tools like cardiovascular echocardiography to evaluate and monitor cardiovascular health, thereby driving the market in the region.

Competitive Landscape and Key Players:The forecast for the cardiovascular echocardiography market can assist stakeholders in formulating their growth strategies. Key players profiled in the cardiovascular echocardiography market report include Apex Heart and Vascular, Ultra-X Imaging, Metropolitan Heart Vascular Institute, Ultromics Limited, Corewell Health, Centinela Hospital Medical Center, Schoolcraft Memorial Hospital, University of Utah Health, Goshen Heart & Vascular Center, and Harefield Hospital. These companies are focused on launching new high-tech products, enhancing existing offerings, and expanding geographically to meet the increasing global consumer demand.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Cardiovascular Echocardiography Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Cardiovascular Echocardiography Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Cardiovascular Echocardiography Market - Global Market Analysis

  • 6.1 Cardiovascular Echocardiography - Global Market Overview
  • 6.2 Cardiovascular Echocardiography - Global Market and Forecast to 2031

7. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By Type, 2021-2031

  • 7.1 Overview
  • 7.2 Transthoracic Echocardiography
  • 7.3 Transesophageal Echocardiography
  • 7.4 Stress Echocardiography
  • 7.5 Fetal Echocardiography

8. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By Technology, 2021-2031

  • 8.1 Overview
  • 8.2 2D echocardiogram
  • 8.3 3D echocardiogram
  • 8.4 Doppler

9. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By End User, 2021-2031

  • 9.1 Overview
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgery Centers
  • 9.4 Diagnostic Labs

10. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Cardiovascular Echocardiography Market Overview
    • 10.1.2 North America Cardiovascular Echocardiography Market Revenue and Forecasts to 2031
    • 10.1.3 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Type
    • 10.1.4 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Technology
    • 10.1.5 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Cardiovascular Echocardiography Market
        • 10.1.6.1.1 United States Cardiovascular Echocardiography Market, by Type
        • 10.1.6.1.2 United States Cardiovascular Echocardiography Market, by Technology
        • 10.1.6.1.3 United States Cardiovascular Echocardiography Market, by End User
      • 10.1.6.2 Canada Cardiovascular Echocardiography Market
        • 10.1.6.2.1 Canada Cardiovascular Echocardiography Market, by Type
        • 10.1.6.2.2 Canada Cardiovascular Echocardiography Market, by Technology
        • 10.1.6.2.3 Canada Cardiovascular Echocardiography Market, by End User
      • 10.1.6.3 Mexico Cardiovascular Echocardiography Market
        • 10.1.6.3.1 Mexico Cardiovascular Echocardiography Market, by Type
        • 10.1.6.3.2 Mexico Cardiovascular Echocardiography Market, by Technology
        • 10.1.6.3.3 Mexico Cardiovascular Echocardiography Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Cardiovascular Echocardiography Market - Key Company Profiles

  • 13.1 Apex Heart and Vascular
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Ultra-X Imaging
  • 13.3 Metropolitan Heart Vascular Institute
  • 13.4 Ultromics Limited
  • 13.5 Corewell Health
  • 13.6 Centinela Hospital Medical Center
  • 13.7 Schoolcraft Memorial Hospital
  • 13.8 University of Utah Health
  • 13.9 Goshen Heart and Vascular Center
  • 13.10 Harefield Hospital

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud